Ajuste de dosis y seguimiento Los efectos secundarios pueden aumentar temporalmente tras una subida de dosis
Product Information Reviews Review Graph 5 star 100% 4 star 0% 3 star 0% 2 star 0% 1 star 0% Show More + Show Less - Benisse B Tiene un fuerte olor a alcohol, las tabletas son bastante grandes y con una textura pastosa si demoras mucho con ella en la boca
SPL UNCLASSIFIED SECTION Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
1 START ONLINE Take 3-minute questionnaire A licensed provider will review your answers and personalize your care
The use of this image is permitted to the author of the piece 3
Interest in weight management supplements continues to grow, particularly those associated with GLP-1-related metabolic pathways
